NCT00469066

Brief Summary

To study changes in tumor and normal organ size and/or position which occur during a course of radiation treatments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2007

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 2, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 4, 2007

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2009

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2010

Completed
Last Updated

February 24, 2016

Status Verified

December 1, 2011

Enrollment Period

2.3 years

First QC Date

May 2, 2007

Last Update Submit

February 23, 2016

Conditions

Lung NeoplasmSmall Cell CarcinomaBladder Carcinoma

Keywords

small cell lung cancerbladder cancerconformal radiotherapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

primary care clniic

You may qualify if:

  • Patient has biopsy proven limited stage SCLC
  • receiving radical concurrent chemoradiotherapy
  • no prior chest RT
  • no prior surgical resection of lung tumor
  • no prior chemotherapy
  • patients' lung tumors should be centrally-located to minimize the effect of respiratory motion
  • patient has biopsy proven TCC bladder
  • receiving radical concurrent chemoradiotherapy or RT alone
  • no prior chemotherapy
  • patient signs study-specific consent form

You may not qualify if:

  • mixed small cell and non small cell histology
  • patient not being treated with concurrent chemoradiotherapy
  • chemoradiotherapy given sequentially
  • previous chest RT
  • previous chemotherapy
  • prior surgical resection of lung mass
  • patient ineligible for pelvic RT
  • patient does not sign study consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cross Cancer Institute

Edmonton, Alberta, Canada

Location

MeSH Terms

Conditions

Lung NeoplasmsCarcinoma, Small CellUrinary Bladder NeoplasmsSmall Cell Lung Carcinoma

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeUrologic NeoplasmsUrogenital NeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital DiseasesCarcinoma, BronchogenicBronchial Neoplasms

Study Officials

  • Don Yee, MD

    AHS Cancer Control Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2007

First Posted

May 4, 2007

Study Start

May 1, 2007

Primary Completion

August 1, 2009

Study Completion

April 1, 2010

Last Updated

February 24, 2016

Record last verified: 2011-12

Locations

CA(1)